View
Foundation Medicine Announces
A Call for Grants Notification (CGN) Focused on Disparities in Biomarker Testing
As part of Foundation Medicine’s Advancing Inclusive Diagnostics Initiative, Foundation Medicine has announced a Call for Grants Notification (CGN) focused on disparities in biomarker testing. This CGN allows interested parties to submit a grant proposal to secure funding for projects and initiatives aimed at increasing biomarker testing education, awareness, and access among underserved populations in the United States.
Updates From Foundation Medicine
Recent Research
-
November 29, 2022
Research Spotlight: Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab
-
October 26, 2022
Research Spotlight: Tumor fraction correlates with detection of actionable variants across >23,000 ctDNA samples
From the Foundation Forward Blog
-
August 09, 2022
A Hub for Innovation: Establishing our Presence in San Diego, California
-
July 06, 2022
One Million Patient Reports Delivered from FoundationOne Portfolio of Tests
-
June 09, 2022
Companion Diagnostics Explained: Their Critical Role in Cancer Care and Our Latest Approvals | Foundation Medicine
-
June 03, 2022
What’s Next With Priti Hegde: Is a genomics-led treatment approach in early-stage cancer the next frontier for precision medicine?
-
March 30, 2022
Celebrating Women’s History Month: A Q&A with Foundation Medicine’s CMO, Mia Levy, MD, PhD